[1]
G, B. et al. 2025. Advancements in SGLT2 inhibitors: pharmacokinetics, pharmacodynamics, and clinical efficacy with a focus on pharmacogenomics. Prospects in Pharmaceutical Sciences. 23, 1 (Mar. 2025), 116–128. DOI:https://doi.org/10.56782/pps.274.